Literature DB >> 35850785

Age and the Course of GFR in Persons Aged 70 and Above.

Elke S Schaeffner1, Natalie Ebert2, Martin K Kuhlmann3, Peter Martus4, Nina Mielke2, Alice Schneider5, Markus van der Giet6, Dörte Huscher5.   

Abstract

BACKGROUND AND OBJECTIVES: In older adults, data on the age-related course of GFR are scarce, which might lead to misjudgment of the clinical relevance of reduced GFR in old age. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To describe the course of eGFR in older adults and derive reference values in population-based individuals, we used the longitudinal design of the Berlin Initiative Study (BIS) with a repeated estimation of GFR over a median of 6.1 years of follow-up. In 2069 community-dwelling older individuals (mean inclusion age 80 years, range 70-99), GFR was estimated biennially with the BIS-2 equation, including standardized creatinine and cystatin C levels, sex, and age. We described the crude and adjusted course using a mixed-effects model and analyzed the influence of death on the GFR course applying joint models. GFR slopes were compared using GFR equations on the basis of creatinine and/or cystatin C.
RESULTS: We observed a decreasing, thus nonlinear, eGFR decline with increasing age in a population of old adults. The estimated 1-year slope for ages 75 and 90 diminished for men from -1.67 to -0.99 and for women from -1.52 to -0.97. The modeled mean eGFR for men aged ≥79 and women ≥78 was below 60 ml/min per 1.73 m2. Multivariable adjustment attenuated slopes only minimally. Taking death into account by applying joint models did not alter the nonlinear eGFR decline. Using eGFR equations on the basis of creatinine only showed linear slope patterns in contrast to nonlinear patterns for equations including cystatin C.
CONCLUSIONS: The eGFR decline depended on sex and age and changed only marginally after multivariable adjustment but decelerated with increasing age. Equations including cystatin C demonstrated a nonlinear slope challenging the previously assumed linearity of the decline of eGFR in old age.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; geriatric nephrology; glomerular filtration rate; renal function decline

Year:  2022        PMID: 35850785      PMCID: PMC9435992          DOI: 10.2215/CJN.16631221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  29 in total

1.  The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach.

Authors:  Elke S Schaeffner; Markus van der Giet; Jens Gaedeke; Markus Tölle; Natalie Ebert; Martin K Kuhlmann; Peter Martus
Journal:  Eur J Epidemiol       Date:  2010-01-22       Impact factor: 8.082

2.  GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts.

Authors:  Bjørn O Eriksen; Runolfur Palsson; Natalie Ebert; Toralf Melsom; Markus van der Giet; Vilmundur Gudnason; Olafur S Indridason; Lesley A Inker; Trond G Jenssen; Andrew S Levey; Marit D Solbu; Hocine Tighiouart; Elke Schaeffner
Journal:  J Am Soc Nephrol       Date:  2020-06-04       Impact factor: 10.121

3.  Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.

Authors:  Linnea Malmgren; Fiona E McGuigan; Sofia Berglundh; Kerstin Westman; Anders Christensson; Kristina Åkesson
Journal:  Nephron       Date:  2015-07-15       Impact factor: 2.847

4.  Normal reference values for glomerular filtration rate: what do we really know?

Authors:  Pierre Delanaye; Elke Schaeffner; Natalie Ebert; Etienne Cavalier; Christophe Mariat; Jean-Marie Krzesinski; Olivier Moranne
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

5.  Longitudinal studies on the rate of decline in renal function with age.

Authors:  R D Lindeman; J Tobin; N W Shock
Journal:  J Am Geriatr Soc       Date:  1985-04       Impact factor: 5.562

6.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

Review 7.  The global burden of chronic kidney disease: estimates, variability and pitfalls.

Authors:  Richard J Glassock; David G Warnock; Pierre Delanaye
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

8.  Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; John W Kusek; Julia B Lewis; Xuelei Wang; Michael S Lipkowitz; Keith C Norris; George L Bakris; Mahboob Rahman; Gabriel Contreras; Stephen G Rostand; Joel D Kopple; Francis B Gabbai; Gerald I Schulman; Jennifer J Gassman; Jeanne Charleston; Lawrence Y Agodoa
Journal:  Arch Intern Med       Date:  2008-04-28

9.  Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women.

Authors:  Linnea Malmgren; Fiona E McGuigan; Anders Christensson; Kristina E Akesson
Journal:  Nephron       Date:  2020-05-11       Impact factor: 2.847

10.  Renal function decline in older men and women with advanced chronic kidney disease-results from the EQUAL study.

Authors:  Nicholas C Chesnaye; Friedo W Dekker; Marie Evans; Fergus J Caskey; Claudia Torino; Maurizio Postorino; Maciej Szymczak; Chava L Ramspek; Christiane Drechsler; Christoph Wanner; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2020-06-27       Impact factor: 5.992

View more
  1 in total

1.  Physiology of the Aging Kidney: We Know Where We Are Going, but We Don't Know How….

Authors:  Pierre Delanaye; Hans Pottel; Toralf Melsom
Journal:  Clin J Am Soc Nephrol       Date:  2022-07-18       Impact factor: 10.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.